Sun Pharmaceutical Industries Limited (Sun Pharma) announced new data showcasing the efficacy and safety of its dermatology portfolio at the 33rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. Notably, LEQSELVI (deuruxolitinib) demonstrated improved hair satisfaction and significant improvement in depression and anxiety for patients with severe alopecia areata. Additional data presented positive results for ILUMYA (tildrakizumab) in moderate-to-severe plaque psoriasis.
Results for: Sun Pharma
Several leading Indian companies, including Adani Green Energy, Sun Pharma, and Adani Energy Solutions, have pledged to achieve net-zero emissions in the coming decades. These companies recognize the urgency of addressing climate change and are committed to playing their part in reducing greenhouse gas emissions.